Aurelius SE & Co. KGaA

M&A Activity • Jul 23, 2015

News Details

Corporate | 23 July 2015 07:30

Aurelius acquires cosmetic surgery group Transform

AURELIUS AG / Key word(s): Acquisition

2015-07-23 / 07:30

---

Aurelius acquires cosmetic surgery group Transform

Munich/London, 23 July, 2015 – Aurelius Group (ISIN DE000A0JK2A8) (“Aurelius”), the pan-European, mid-market investor, confirms that it has completed the acquisition of Transform Medical Group Limited (“Transform” or “the Company”), one of the UK’s leading providers of surgical and non-surgical cosmetic procedures, for an undisclosed sum.

Founded in 1974, Transform comprises 27 clinics across England, Scotland, Wales and Northern Ireland, as well as two dedicated cosmetic surgery hospitals in Manchester and London. The Company also has partnerships with third-party hospitals in Scotland, Northern Ireland and the South East of England. Over time the Transform brand has become a hallmark for sector clinical excellence and delivering a highly distinct patient-centric offering. Transform’s integrated model allows it to care for patients throughout their journey, from initial enquiry to post-operative care.

Dr. Dirk Markus, Chief Executive of Aurelius Group, commented: “Transform is a market leader in cosmetic surgery in the UK. Over the past 40 years, following investment into a vertically integrated national network of hospitals and clinics, Transform has developed an enviable reputation for clinical excellence, regulatory compliance and high quality aftercare. We look forward to working with the Company to grow the business in a sector that is currently experiencing attractive demand drivers.”

ABOUT AURELIUS

AURELIUS is one of the leading European investment groups. From its offices in Munich, London, Stockholm and Madrid, AURELIUS acquires participations with development potential. Once under the AURELIUS umbrella, the acquisitions are given a long-term strategic orientation in order for them to fully develop their potential.

Currently, the AURELIUS Group consists of 20 subsidiaries with locations in Europe, Asia, and the U.S.A. These include numerous traditional consumer brands, services businesses and a number of industrial enterprises. Companies are acquired based on strict investment criteria without focusing on any particular industry. Shares of AURELIUS AG are listed in the m:access segment of the Munich Stock Exchange and are traded on all German stock markets under ISIN DE000A0JK2A8.

To find out more, visit www.aureliusinvest.com

CONTACT

Anke Banaschewski

Investor Relations & Corporate Communications

Phone +49 (89) 544799 – 0

Fax +49 (89) 544799 – 55

investor@aureliusinvest.de

About Transform

Transform is the UK’s longest established cosmetic surgery provider with over 40 years’ experience in providing high quality patient care across surgical and non-surgical treatments.

A combination of expert surgeons, dedicated cosmetic surgery hospitals, comprehensive aftercare and caring committed staff sets Transform apart from other providers.

With 27 clinics and 2 hospitals, Transform is proud to be leading the way in helping the industry raise clinical standards as well as creating a positive and professional image of the sector as a whole.

Transform is a patient focused organisation committed to excellent clinical care and outstanding results.

---

2015-07-23 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

380281  2015-07-23